Khoury_2018_Ther.Adv.Drug.Saf_9_171

Reference

Title : An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine - Khoury_2018_Ther.Adv.Drug.Saf_9_171
Author(s) : Khoury R , Rajamanickam J , Grossberg GT
Ref : Ther Adv Drug Safety , 9 :171 , 2018
Abstract : Khoury_2018_Ther.Adv.Drug.Saf_9_171
ESTHER : Khoury_2018_Ther.Adv.Drug.Saf_9_171
PubMedSearch : Khoury_2018_Ther.Adv.Drug.Saf_9_171
PubMedID: 29492246

Related information

Citations formats

Khoury R, Rajamanickam J, Grossberg GT (2018)
An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine
Ther Adv Drug Safety 9 :171

Khoury R, Rajamanickam J, Grossberg GT (2018)
Ther Adv Drug Safety 9 :171